Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs ...

short for glucagon-like peptide 1 and sold under brand names like Ozempic, Wegovy and Mounjaro to treat diabetes and obesity. Sarah Laing is a Toronto-based freelance contributor for The Star ...

Ozempic, Wegovy and similar drugs are, without a doubt, revolutionising medicine. They have transformed our ability to manage obesity and type 2 diabetes, but have actually shown potential for a ...

It’s a question that’s become nearly as common as “have you seen Wicked yet?” Ozempic and other GLP-1 drugs, like Wegovy or Zepbound, have transformed the way we think about our bodies ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to ... the FDA changed the status of all dosages of Ozempic and Wegovy to “available ...

Glucagon-like peptide-1 receptor agonists such as Ozempic, originally developed for diabetes management and later approved for weight loss, are being studied for their potential to address age ...